BELOTTI DANIELA

Pubblicazioni

  • Introna, M., Lussana, F., Algarotti, A., Gotti, E., Valgardsdottir, R., Micò, C., et al. (2017). Phase II Study of Sequential Infusion of Donor Lymphocyte Infusion and Cytokine-Induced Killer Cells for Patients Relapsed after Allogeneic Hematopoietic Stem Cell Transplantation. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 23(12), 2070-2078. Dettaglio
  • Belotti, D., Gaipa, G., Bassetti, B., Cabiati, B., Spaltro, G., Biagi, E., et al. (2015). Full GMP-Compliant Validation of Bone Marrow-Derived Human CD133+ Cells as Advanced Therapy Medicinal Product for Refractory Ischemic Cardiomyopathy. BIOMED RESEARCH INTERNATIONAL. Dettaglio
  • Introna, M., Lucchini, G., Dander, E., Galimberti, S., Rovelli, A., Balduzzi, A., et al. (2014). Treatment of Graft versus Host Disease with Mesenchymal Stromal Cells: A Phase I Study on 40 Adult and Pediatric Patients. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 20(3), 375-381. Dettaglio
  • Introna, M., Lucchini, G., Dander, E., Rovelli, A., Balduzzi, A., Longoni, D., et al. (2012). Safe and Effective Treatment of Graft Versus Host Disease with Platelet Lysate-Expanded Human Mesenchymal Stromal Cells: A Phase 1 Study On 47 Adult and Pediatric Patients. BLOOD, 120(21). Dettaglio
  • Dander, E., Lucchini, G., Vinci, P., Introna, M., Masciocchi, F., Perseghin, P., et al. (2012). Mesenchymal stromal cells for the treatment of graft-versus-host disease: understanding the in vivo biological effect through patient immune monitoring. LEUKEMIA. Dettaglio